|
t******g
发帖数: 462 | 2 不要追高，不过接下来几天如果回调的话是否值得跟进
看不懂产品有多大市场
http://finance.yahoo.com/news/CytoSorbents-Corporation-iw-28021
CytoSorbents Corporation Achieves European Union Regulatory Approval for
CytoSorb(TM)
MONMOUTH JUNCTION, NJ--(Marketwire - 03/31/11) - CytoSorbents Corporation (
OTC.BB:CTSO - News), a critical care focused company using blood
purification to treat life-threatening illnesses, is pleased to announce
that it has achieved European CE Mark approval for its flagship product,
CytoSorb™, as an ext... 阅读全帖 |
|
j*****2
发帖数: 306 | 3 this type of play
either chase, or NOTHING...
at CTSO's case, I favor CHASE.
2009 has a report said 10buck if EU approve, now they get it. Also, only
40million market cap. |
|
|
|
|
s*****r
发帖数: 1745 | 7 Thats the source of the libido for trading pennies. |
|
t*********7
发帖数: 900 | 8
60分钟线RSI在95真超买，但还是上了1万股0.33玩玩，哈哈。 |
|
s*****r
发帖数: 1745 | 9 RSI does not mean shit for pennies. |
|
t*********7
发帖数: 900 | 10 看老外在YAHOO上说，该产品在欧洲市场潜力几十个亿，不知真假。 |
|
s*****r
发帖数: 1745 | 11 as long as you can ring the cash register, who cares? |
|
t******g
发帖数: 462 | 12 200９的ｒｅｐｏｒｔ还能找到吗？ 好像不太靠谱，真要能值１０刀，也不会跌到两
毛了。
还有ｏｔｃ的股票，实在看不懂有多少 ｐｏｔｅｎｔｉａｌ ｄｉｌｕｔｉｏｎ，ｔ
ｍｄ，ｆｉｌｅ的什末狗屁１０－Ｑ，先看一阵再说吧，关键还是要看庄家。
Ｆｒｏｍ １０－Ｑ
Liquidity and Capital Resources
Since inception, our operations have been financed through the private
placement of our debt and equity securities. At December 31, 2009 we had
cash of $1,595,628. As of September 30, 2010 we had cash on hand of $758,224
, and current liabilities of $2,037,809.
In October and November 2010 an additional $258,000 was received by the
Compan... 阅读全帖 |
|
a********h
发帖数: 819 | 13 happens I have played this stock several times since summer 2009.
I sold most Friday with cost 8 cents.
I wouldn't chase here, they have huge amount of preferred shares that can
convert to common shares any time (about potential 300M shares)
so it's not 40M market cap, it's about 140+M market cap if including
preferred (preferred B shares cost 3 cents!)
I mean, at least it's highly risky |
|
a********h
发帖数: 819 | 14 also the 2009 report was a shameless pump.
It pumped the stock to 42 cents then crashed. but the important facts were
missing in that report (it didn't mention the preferred shares, and claim
the trial will be done end of 2009, which was a huge lie) |
|
j*****2
发帖数: 306 | 15 all we need is BIOMED to pump again :D |
|
j*****2
发帖数: 306 | 16 read some info in their message board , it is all about their seconary
endpoint, which will release in 4 to 8week, left imagation for pump. |
|
t******g
发帖数: 462 | 17 Thanks a lot, that's the best dilution analysis on this stock.
Let's see if they will do some more dilution shortly, I might consider buy
lower than their offer price. |
|
